154 related articles for article (PubMed ID: 29506969)
41. Comparing the Efficacy of Targeted and Blast Portal Messaging in Message Opening Rate and Anticoagulation Initiation in Patients With Atrial Fibrillation in the Preventing Preventable Strokes Study II: Prospective Cohort Study.
Kapoor A; Patel P; Chennupati S; Mbusa D; Sadiq H; Rampam S; Leung R; Miller M; Vargas KR; Fry P; Lowe MM; Catalano C; Harrison C; Catanzaro JN; Crawford S; Smith AM
JMIR Cardio; 2024 Jan; 8():e49590. PubMed ID: 38265849
[TBL] [Abstract][Full Text] [Related]
42. A Bottom-Up Approach to Encouraging Sustained User Adoption of a Secure Text Messaging Application.
Tsega S; Kalra A; Sevilla CT; Cho HJ
Appl Clin Inform; 2019 Mar; 10(2):326-330. PubMed ID: 31091544
[TBL] [Abstract][Full Text] [Related]
43. Feasibility and Smokers' Evaluation of Self-Generated Text Messages to Promote Quitting.
Shaw RJ; Pollak K; Zullig LL; Bennett G; Hawkins K; Lipkus I
Nicotine Tob Res; 2016 May; 18(5):1206-9. PubMed ID: 26647104
[TBL] [Abstract][Full Text] [Related]
44. Classification of patient- and clinician-generated secure messages using a theory-based taxonomy.
Heisey-Grove D; Rathert C; McClelland LE; Jackson K; DeShazo J
Health Sci Rep; 2021 Jun; 4(2):e295. PubMed ID: 34084944
[TBL] [Abstract][Full Text] [Related]
45. Two-Way Social Media Messaging in Postoperative Cataract Surgical Patients: Prospective Interventional Study.
Sanguansak T; Morley KE; Morley MG; Thinkhamrop K; Thuanman J; Agarwal I
J Med Internet Res; 2017 Dec; 19(12):e413. PubMed ID: 29258973
[TBL] [Abstract][Full Text] [Related]
46. Nicotine replacement therapy for smoking cessation.
Stead LF; Perera R; Bullen C; Mant D; Hartmann-Boyce J; Cahill K; Lancaster T
Cochrane Database Syst Rev; 2012 Nov; 11():CD000146. PubMed ID: 23152200
[TBL] [Abstract][Full Text] [Related]
47. Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial.
Fu SS; van Ryn M; Sherman SE; Burgess DJ; Noorbaloochi S; Clothier B; Taylor BC; Schlede CM; Burke RS; Joseph AM
JAMA Intern Med; 2014 May; 174(5):671-7. PubMed ID: 24615217
[TBL] [Abstract][Full Text] [Related]
48. Financial IncEntives for Smoking TreAtment: protocol of the FIESTA trial and FIESTA Oral Microbiome Substudy.
French KM; Gonzalez SZ; Sherman SE; Link AR; Malik SZ; Tseng CH; Jumkhawala SA; Tejada B; White A; Ladapo JA
Trials; 2018 Nov; 19(1):646. PubMed ID: 30463608
[TBL] [Abstract][Full Text] [Related]
49. Developing the Message Assessment Scale for Tobacco Prevention Campaigns: Cross-sectional Validation Study.
Rath JM; Perks SN; Williams KN; Budnik T; Geraci J; Vallone DM; Hair EC
JMIR Form Res; 2022 Jul; 6(7):e38156. PubMed ID: 35881429
[TBL] [Abstract][Full Text] [Related]
50. An integrated digital/clinical approach to smoking cessation in lung cancer screening: study protocol for a randomized controlled trial.
Graham AL; Burke MV; Jacobs MA; Cha S; Croghan IT; Schroeder DR; Moriarty JP; Borah BJ; Rasmussen DF; Brookover MJ; Suesse DB; Midthun DE; Hays JT
Trials; 2017 Nov; 18(1):568. PubMed ID: 29179734
[TBL] [Abstract][Full Text] [Related]
51. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
52. Proactive Tobacco Treatment for Smokers Using Veterans Administration Mental Health Clinics.
Rogers ES; Fu SS; Krebs P; Noorbaloochi S; Nugent SM; Gravely A; Sherman SE
Am J Prev Med; 2018 May; 54(5):620-629. PubMed ID: 29551324
[TBL] [Abstract][Full Text] [Related]
53. Impact of implementing a tobacco and recreational nicotine-free policy and enhanced treatments on programmatic and patient-level outcomes within a residential substance use disorder treatment program.
Hemmy Asamsama O; Miller SC; Silvestri MM; Bonanno C; Krondilou K
J Subst Abuse Treat; 2019 Dec; 107():44-49. PubMed ID: 31757264
[TBL] [Abstract][Full Text] [Related]
54. Demographics and clinical features associated with rates of electronic message utilization in the primary care setting.
Hansen MA; Hirth J; Zoorob R; Langabeer J
Int J Med Inform; 2024 Mar; 183():105339. PubMed ID: 38219417
[TBL] [Abstract][Full Text] [Related]
55. Associations Between Patient-Provider Secure Message Content and Patients' Health Care Visits.
Heisey-Grove D; McClelland LE; Rathert C; Jackson K; DeShazo J
Telemed J E Health; 2022 May; 28(5):690-698. PubMed ID: 34569867
[No Abstract] [Full Text] [Related]
56. Insecure messaging: how clinicians approach potentially problematic messages from patients.
Lee JL; Matthias MS; Huffman M; Frankel RM; Weiner M
JAMIA Open; 2020 Dec; 3(4):576-582. PubMed ID: 33758796
[TBL] [Abstract][Full Text] [Related]
57. Initial experience with patient-clinician secure messaging at a VA medical center.
Byrne JM; Elliott S; Firek A
J Am Med Inform Assoc; 2009; 16(2):267-70. PubMed ID: 19074303
[TBL] [Abstract][Full Text] [Related]
58. The Rules of Engagement: Perspectives on Secure Messaging From Experienced Ambulatory Patient Portal Users.
Sieck CJ; Hefner JL; Schnierle J; Florian H; Agarwal A; Rundell K; McAlearney AS
JMIR Med Inform; 2017 Jul; 5(3):e13. PubMed ID: 28676467
[TBL] [Abstract][Full Text] [Related]
59. Association of Patient Portal Messaging with Survival Among Radiation Oncology Patients.
Alexander J; Beatty A
Int J Radiat Oncol Biol Phys; 2024 May; ():. PubMed ID: 38723754
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
